Cancer causes a great number of death every year in the world and has been destroying numerous happy families. Both the government and individuals spend vast sums of money on cancer, which makes cancer a great burden to the society. Due to its properties and therapeutic operations, patients with cancer are often accompany with anemia. Red blood cell (RBC) transfusion is a preferred symptomatic treatment strategy. But, considering side effects, optimal protocol of blood transfusion for cancer patients is still in air. Though much work has been done, there are still continuous arguments on the adverse effects of blood transfusion on cancer prognosis. By reviewing these works, we focused on the essential elements of transfusion, i.e. the time and dose of blood transfusion, as well as the type and source of blood product. Though we failed to find a definite answer, previous studies indicated some clues on the relationships between cancer prognosis and these elements. Transfusion prior to surgery and reduction of intraoperative and postoperative blood demand may be beneficial. As for RBC type, autologous leucocyte-depleted RBC might have priority. However, more high-quality randomized clinical trials are needed to settle those questions. Furtherly, this narrative review suggested some critical ideas on further studies.
| Published in | Journal of Cancer Treatment and Research (Volume 9, Issue 4) |
| DOI | 10.11648/j.jctr.20210904.12 |
| Page(s) | 63-66 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Blood Transfusion, Cancer, Prognosis
| [1] | Chen WQ, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2014. Chinese Journal of Cancer Research. 2018; 30 (1): 1-12. |
| [2] | Sun DQ, Cao MM, Li H, et al. Cancer burden and trends in China: A review and comparison with Japan and South Korea. Chin J Cancer Res. 2020; 32 (2): 129-39. |
| [3] | Su MZ, Lao JH, Zhang N, et al. Financial hardship in Chinese cancer survivors. Cancer. 2020; 126 (14): 3312-21. |
| [4] | Smith PM, Baechle J, Carmen C. Solórzano, et al. Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group. HPB. 2020; 22 (7): 1042-50. |
| [5] | Qiu L, Wang DR, Zhang XY, et al. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients. Transfusion and Apheresis Science. 2016; 54 (2): 235-241. |
| [6] | Heiss MM, Fasol-Merten K, Allgayer H, et al. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sang. 1997; 73: 237-45. |
| [7] | De Oliveira Jr. GS, Schink JC, Buoy C, et al. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer. Transfusion Medicine. 2012; 22 (2): 97-103. |
| [8] | Boshier PR, Ziff C, Adam ME, et al. Effect of perioperative blood transfusion on the long-term survival of patients undergoing esophagectomy for esophageal cancer: a systematic review and meta-analysis. Diseases of the Esophagus. 2018; 31 (4): 1-10. |
| [9] | Zhang H, Wu X, Xu Z, et al. Impact of perioperative red blood cell transfusion on postoperative recovery and long-term outcome in patients undergoing surgery for ovarian cancer: A propensity score-matched analysis. Gynecologic Oncology. 2020; 156 (2): 439-45. |
| [10] | Cui JL, Deng JY, Ding XW, et al. Blood transfusion does not affect survival of gastric cancer patients. Journal of Surgical Research. 2016; 200 (1): 98-104. |
| [11] | Hunsicker O, Gericke S, Graw JA, et al. Transfusion of red blood cells does not impact progression-free and overall survival after surgery for ovarian cancer. Transfusion. 2019; 59 (12): 3589-600. |
| [12] | Lobaziewicz K. The Impact of Homologous Packed Red Blood Cell Transfusion on Patients’ Survival after Radical Surgical Treatment of Colorectal Cancer. Acta Chirurgica Belgica. 2008; 108 (5): 524-31. |
| [13] | Kaneko M, Sasaki S, Ishimaru K, et al. The impact of perioperative allogeneic blood transfusion on survival in elderly patients with colorectal cancer. Anticancer Research. 2015; 35 (6): 3553-8. |
| [14] | McSorley ST, Tham A, Dolan RD, et al. Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer. Annals of Surgical Oncology. 2020; 27 (5): 833-43. |
| [15] | Mueller Markus M VRH, Meybohm Patrick, et al. Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. JAMA. 2019; 321 (10): 983-97. |
| [16] | Miki C, Hiro J, Ojima E, et al. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clinical oncology (Royal College of Radiologists (Great Britain)). 2006; 18 (1): 60-6. |
| [17] | Moschini M, Bianchi M, Gandaglia G, et al. The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status. European Urology Focus. 2016; 2 (1): 86-91. |
| [18] | Moschini M, Bianchi M, Rossi MS, et al. Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. Urologic Oncology. 2016; 34 (6): 256. e7-. e13. |
| [19] | Alexander B, Tobias G, Birte-Swantje S, et al. Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage. Scandinavian Journal of Urology. 2017; 51 (2): 130-6. |
| [20] | Latif MJ, Tan KS, Molena D, et al. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. 2019; 157 (6): 2469-77. e10. |
| [21] | Skånberg J, Lundholm K, Haglind E. Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancer. Acta Oncologica. 2007; 46 (8): 1123-30. |
| [22] | Frederike C. Ling AHH, Daniel Vallböhmer, Daniel Schmidt, Susanne Picker, Birgit S. Gathof, Elfriede Bollschweiler, Paul M. Schneider. Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer. Journal of Gastrointestinal Surgery. 2009; 13 (4): 581-6. |
| [23] | Ling FC, Hoelscher AH, Vallböhmer D, et al. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. The British journal of surgery. 2009; 96 (7): 734-40. |
| [24] | Wang ZB, Liu YQ, Li RE, et al. Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer. Journal of Hematology & Oncology. 2016; 9 (1): 6. |
| [25] | Motoyama S, Saito R, Kamata S, et al. Survival Advantage of Using Autologous Blood Transfusion During Surgery for Esophageal Cancer. Surgery Today. 2002; 32 (11): 951-8. |
| [26] | Motoyama S, Okuyama M, Kitamura M, et al. Use of Autologous Instead of Allogeneic Blood Transfusion During Esophagectomy Prolongs Disease-Free Survival Among Patients With Recurrent Esophageal Cancer. Journal of Surgical Oncology. 2004; 87: 26–31. |
| [27] | Kim JK, Kim HS, Park J, et al. Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer. PLoS ONE. 2017; 11 (5): e0154918. |
| [28] | Rzyman W, Dziadziuszko R, Skokowski J, et al. The influence of blood transfusion on survival in operated non-small cell lung cancer patients. The Journal of Thoracic and Cardiovascular Surgery. 2003; 126 (3): 755-60. |
APA Style
Rui Zhou, Liehong Yang, Ru Yu. (2021). Controversial Role of Blood Transfusion on Outcomes of Patients with Cancer: A Focused Review. Journal of Cancer Treatment and Research, 9(4), 63-66. https://doi.org/10.11648/j.jctr.20210904.12
ACS Style
Rui Zhou; Liehong Yang; Ru Yu. Controversial Role of Blood Transfusion on Outcomes of Patients with Cancer: A Focused Review. J. Cancer Treat. Res. 2021, 9(4), 63-66. doi: 10.11648/j.jctr.20210904.12
AMA Style
Rui Zhou, Liehong Yang, Ru Yu. Controversial Role of Blood Transfusion on Outcomes of Patients with Cancer: A Focused Review. J Cancer Treat Res. 2021;9(4):63-66. doi: 10.11648/j.jctr.20210904.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jctr.20210904.12,
author = {Rui Zhou and Liehong Yang and Ru Yu},
title = {Controversial Role of Blood Transfusion on Outcomes of Patients with Cancer: A Focused Review},
journal = {Journal of Cancer Treatment and Research},
volume = {9},
number = {4},
pages = {63-66},
doi = {10.11648/j.jctr.20210904.12},
url = {https://doi.org/10.11648/j.jctr.20210904.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jctr.20210904.12},
abstract = {Cancer causes a great number of death every year in the world and has been destroying numerous happy families. Both the government and individuals spend vast sums of money on cancer, which makes cancer a great burden to the society. Due to its properties and therapeutic operations, patients with cancer are often accompany with anemia. Red blood cell (RBC) transfusion is a preferred symptomatic treatment strategy. But, considering side effects, optimal protocol of blood transfusion for cancer patients is still in air. Though much work has been done, there are still continuous arguments on the adverse effects of blood transfusion on cancer prognosis. By reviewing these works, we focused on the essential elements of transfusion, i.e. the time and dose of blood transfusion, as well as the type and source of blood product. Though we failed to find a definite answer, previous studies indicated some clues on the relationships between cancer prognosis and these elements. Transfusion prior to surgery and reduction of intraoperative and postoperative blood demand may be beneficial. As for RBC type, autologous leucocyte-depleted RBC might have priority. However, more high-quality randomized clinical trials are needed to settle those questions. Furtherly, this narrative review suggested some critical ideas on further studies.},
year = {2021}
}
TY - JOUR T1 - Controversial Role of Blood Transfusion on Outcomes of Patients with Cancer: A Focused Review AU - Rui Zhou AU - Liehong Yang AU - Ru Yu Y1 - 2021/12/07 PY - 2021 N1 - https://doi.org/10.11648/j.jctr.20210904.12 DO - 10.11648/j.jctr.20210904.12 T2 - Journal of Cancer Treatment and Research JF - Journal of Cancer Treatment and Research JO - Journal of Cancer Treatment and Research SP - 63 EP - 66 PB - Science Publishing Group SN - 2376-7790 UR - https://doi.org/10.11648/j.jctr.20210904.12 AB - Cancer causes a great number of death every year in the world and has been destroying numerous happy families. Both the government and individuals spend vast sums of money on cancer, which makes cancer a great burden to the society. Due to its properties and therapeutic operations, patients with cancer are often accompany with anemia. Red blood cell (RBC) transfusion is a preferred symptomatic treatment strategy. But, considering side effects, optimal protocol of blood transfusion for cancer patients is still in air. Though much work has been done, there are still continuous arguments on the adverse effects of blood transfusion on cancer prognosis. By reviewing these works, we focused on the essential elements of transfusion, i.e. the time and dose of blood transfusion, as well as the type and source of blood product. Though we failed to find a definite answer, previous studies indicated some clues on the relationships between cancer prognosis and these elements. Transfusion prior to surgery and reduction of intraoperative and postoperative blood demand may be beneficial. As for RBC type, autologous leucocyte-depleted RBC might have priority. However, more high-quality randomized clinical trials are needed to settle those questions. Furtherly, this narrative review suggested some critical ideas on further studies. VL - 9 IS - 4 ER -
Information
Email: